Skip to main content

Table 3 Changes in plasma ANP and aldosterone levels during the evaluation period

From: Effect of γ-tocopherol supplementation on premenstrual symptoms and natriuresis: a randomized, double-blind, placebo-controlled study

 

Follicular

phase (F)

Placebo intake

(Luteal phase)

p-value

vs. F

γ-Toc intake

(Luteal phase)

p-value

vs. Placebo intake

ANP (pg/mL)

 E-D1

27.0 ± 2.8

21.9 ± 1.6

0.041

25.7 ± 2.3

0.059

 E-D3

35.5 ± 2.8

32.1 ± 2.5

0.184

42.8 ± 5.4

0.007

Aldosterone (pg/mL)

 E-D1

189.3 ± 16.8

317.6 ± 29.1

 < 0.001

278.3 ± 34.9

0.199

 E-D3

109.9 ± 8.4

173.0 ± 12.1

 < 0.001

138.7 ± 14.2

0.013

  1. ANP Atrial natriuretic peptide